The New York Times: UB study shows St. John's wort may reduce effectiveness of anticancer drug

By Arthur Page

Release Date: November 2, 2004 This content is archived.

Print

An article in The New York Times reports on a UB study that showed that some cancer patients on a common medication are being warned to stay away from St. John's wort because the herbal supplement appears to reduce the effectiveness of the anticancer drug. The article quotes Patrick F. Smith, assistant professor of pharmacy and pharmaceutical sciences. Go to article.